Acasti Pharma | ACST - Selling And Administration Expenses

Stock Price
3.75
Daily Change
0 0%
Monthly
3.31%
Yearly
17.92%
Q1 Forecast
3.54

Acasti Pharma reported $1.96M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Acasti Pharma USD 1.96M 180K Sep/2025
Addus HomeCare USD 79.37M 2.29M Sep/2025
Amarin USD 17.94M 17.86M Sep/2025
Cassava Sciences USD 7.9M 1.08M Sep/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Option Care Health USD 172.1M 2.01M Sep/2025
Organigram Holdings CAD 8.86M 499K Sep/2025
Tilray USD 24.85M 1.7M Sep/2025